GB Patent

GB2406791A — Foam formulation of minoxidil

Assigned to NUPHARM LAB Ltd · Expires 2005-04-13 · 21y expired

What this patent protects

A pharmaceutical dosage form comprises an active ingredient selected <SL> <LI>minoxidil, minoxidil sulphate, other soluble minoxidil salts and mixtures thereof; <LI>a surfactant; <LI>water; and <LI>optional further excipients; </SL> the formula…

USPTO Abstract

A pharmaceutical dosage form comprises an active ingredient selected <SL> <LI>minoxidil, minoxidil sulphate, other soluble minoxidil salts and mixtures thereof; <LI>a surfactant; <LI>water; and <LI>optional further excipients; </SL> the formulation being adapted to form a foam when administered by spraying. Composition comprising minoxidil or minoxidil sulphate and propylene glycol and and cocamidopropyl betaine are exemplified.

Drugs covered by this patent

Patent Metadata

Patent number
GB2406791A
Jurisdiction
GB
Classification
—
Expires
2005-04-13
Drug substance claim
No
Drug product claim
No
Assignee
NUPHARM LAB Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.